This post was written by Paul Sheives. FDA has issued a draft guidance document entitled “Public Availability of Advisory Committee Members’ Financial Interest Information and Waivers.” The document highlights FDA procedures regarding the public nature of financial interests of advisory committee members and waivers granted by FDA to allow committee members to participate. FDA is accepting comments on this draft guidance until June 21, 2010.